ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $730,402 | -12.3% | 28,114 | -3.0% | 0.00% | -33.3% |
| Q1 2023 | $832,650 | +0.1% | 28,992 | +3.1% | 0.01% | -14.3% |
| Q4 2022 | $832,115 | +23.3% | 28,112 | -0.8% | 0.01% | 0.0% |
| Q3 2022 | $675,000 | +113.6% | 28,352 | +100.5% | 0.01% | +133.3% |
| Q2 2022 | $316,000 | -57.5% | 14,142 | -52.3% | 0.00% | -25.0% |
| Q1 2022 | $744,000 | -10.8% | 29,641 | +27.3% | 0.00% | 0.0% |
| Q4 2021 | $834,000 | +33.4% | 23,278 | +58.4% | 0.00% | 0.0% |
| Q3 2021 | $625,000 | -30.3% | 14,692 | -29.1% | 0.00% | -33.3% |
| Q2 2021 | $897,000 | -22.8% | 20,717 | -27.3% | 0.01% | -25.0% |
| Q1 2021 | $1,162,000 | +378.2% | 28,491 | +429.7% | 0.01% | +300.0% |
| Q4 2020 | $243,000 | -42.3% | 5,379 | -54.8% | 0.00% | -60.0% |
| Q3 2020 | $421,000 | +52.0% | 11,891 | +62.0% | 0.01% | +25.0% |
| Q2 2020 | $277,000 | -71.5% | 7,342 | -60.8% | 0.00% | -73.3% |
| Q4 2019 | $971,000 | -26.0% | 18,719 | -21.7% | 0.02% | -28.6% |
| Q3 2019 | $1,312,000 | +41.8% | 23,911 | +5.0% | 0.02% | +31.2% |
| Q2 2019 | $925,000 | +48.0% | 22,766 | +10.2% | 0.02% | +60.0% |
| Q1 2019 | $625,000 | – | 20,658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |